Functional analysis of a de novo variant in the neurodevelopment and generalized epilepsy disease gene NBEA

Mol Genet Metab. 2021 Sep-Oct;134(1-2):195-202. doi: 10.1016/j.ymgme.2021.07.013. Epub 2021 Aug 9.

Abstract

Neurobeachin (NBEA) was initially identified as a candidate gene for autism. Recently, variants in NBEA have been associated with neurodevelopmental delay and childhood epilepsy. Here, we report on a novel NBEA missense variant (c.5899G > A, p.Gly1967Arg) in the Domain of Unknown Function 1088 (DUF1088) identified in a child enrolled in the Undiagnosed Diseases Network (UDN), who presented with neurodevelopmental delay and seizures. Modeling of this variant in the Caenorhabditis elegans NBEA ortholog, sel-2, indicated that the variant was damaging to in vivo function as evidenced by altered cell fate determination and trafficking of potassium channels in neurons. The variant effect was indistinguishable from that of the reference null mutation suggesting that the variant is a strong hypomorph or a complete loss-of-function. Our experimental data provide strong support for the molecular diagnosis and pathogenicity of the NBEA p.Gly1967Arg variant and the importance of the DUF1088 for NBEA function.

Keywords: C. elegans; Epilepsy; Neurobeachin; Neurodevelopmental delay; SEL-2.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caenorhabditis elegans / genetics
  • Caenorhabditis elegans Proteins / genetics
  • Carrier Proteins / genetics*
  • Child
  • Epilepsy / genetics*
  • Female
  • Gene Editing
  • Genetic Variation*
  • Humans
  • Nerve Tissue Proteins / genetics*
  • Neurodevelopmental Disorders / genetics*
  • Pathology, Molecular
  • Potassium Channels / metabolism

Substances

  • Caenorhabditis elegans Proteins
  • Carrier Proteins
  • NBEA protein, human
  • Nerve Tissue Proteins
  • Potassium Channels
  • SEL-2 protein, C elegans